CION Ameerpet
Lymphoblastic lymphoma is a fast-growing but highly treatable non-Hodgkin lymphoma of childhood, most often of the T-cell type. This guide explains what it is, the early signs to watch for, and how CION's team plans intensive, coordinated care.
Childhood lymphoblastic lymphoma is an aggressive but highly treatable type of non-Hodgkin lymphoma. It develops from lymphoblasts — immature lymphocytes, the white blood cells that fight infection — before they have finished maturing. It is one of the more common lymphomas in children and teenagers, and it is closely related to the parent condition, lymphoblastic lymphoma, seen across all ages.
The majority of cases in children are of T-cell origin — often called child T-cell lymphoma — and these frequently appear as a mass in the chest, behind the breastbone. A smaller share are of B-cell origin, which more often involve the skin, bone or lymph nodes. Because these tumours grow quickly, they are diagnosed and treated promptly, using intensive combination chemotherapy.
This page is a parent-friendly bridge into CION's paediatric lymphoma resources. For the wider view of lymphoma in young people, read our overview of lymphoma in children, and explore the full lymphoma hub. Treatment specifics are covered on our lymphoma treatment in Hyderabad page.
Lymphoblastic lymphoma and acute lymphoblastic leukaemia (ALL) come from the same immature lymphoblast cell — they are essentially two presentations of one disease. By convention, when the bone marrow contains more than about 25% lymphoblasts it is classified as leukaemia; below that, with disease mainly forming solid masses, it is called lymphoblastic lymphoma. This is why children with lymphoblastic lymphoma are treated with intensive leukaemia-style protocols. (Source: WHO classification of haematolymphoid tumours, as referenced in NCCN and ESMO paediatric lymphoma guidance.)
Symptoms depend on where the lymphoma is. Because T-cell disease often forms a chest mass, breathing symptoms can come on quickly — any child with fast-worsening breathing should be seen the same day.
Most of these signs have ordinary causes and are not lymphoma. What matters is a pattern that is persistent and progressive rather than settling. If your child has these signs, speak to a CION specialist for a prompt assessment.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just had a diagnosis, want to understand what T-cell lymphoblastic lymphoma means for your child, or need a second opinion before treatment? CION's team is here to help.
Parents often hear both terms, and the overlap can be confusing. Lymphoblastic lymphoma and acute lymphoblastic leukaemia arise from the same immature lymphoblast cells and share much of their biology. The difference is where the disease mainly sits.
Because the two conditions are so closely related, paediatric lymphoblastic lymphoma is generally treated with leukaemia-style protocols. The exact regimen names are decided with your treating team and summarised on our lymphoma treatment page.
Reaching a precise diagnosis — and confirming whether it is a T-cell or B-cell lymphoma — takes a careful, step-by-step pathway. CION delivers the imaging, biopsy coordination, bone-marrow examination and immunophenotyping directly, following NCCN and ESMO guidance.
A chest X-ray and CT are used to look for a mediastinal (chest) mass, which is common in T-cell disease, and to map involved lymph nodes elsewhere in the body. Imaging helps assess how much disease is present and whether it is pressing on the airway or nearby structures.
The diagnosis is confirmed on tissue. A biopsy of an involved node or mass is examined under the microscope, and immunophenotyping identifies the lymphoblasts and classifies them as T-cell (child T-cell lymphoma) or B-cell. This distinction shapes the plan. Biopsy steps are coordinated with our surgical partners; the laboratory work is delivered directly.
A bone-marrow examination checks how much marrow is involved (which distinguishes lymphoma from leukaemia), and a lumbar puncture samples the fluid around the brain and spinal cord to look for central-nervous-system involvement. Both findings directly influence staging and the intensity of treatment.
In children with T-cell lymphoblastic lymphoma, the disease often shows up first as a mass in the chest behind the breastbone rather than as swollen neck glands. If that mass presses on the windpipe or the large vein returning blood to the heart, breathing symptoms and facial swelling can develop quickly — which is why this presentation is treated as an urgent situation. (Source: presentation patterns described in NCCN and ESMO paediatric non-Hodgkin lymphoma guidance.)
Because lymphoblastic lymphoma behaves like acute lymphoblastic leukaemia, it is treated with intensive, prolonged combination chemotherapy given in phases over roughly two years. Every child's case is reviewed by CION's multidisciplinary tumour board before the plan is set. The main building blocks are:
Treatment follows a phased, leukaemia-style approach — an initial intensive phase to bring the disease under control, followed by consolidation and a longer maintenance phase. CION's team delivers systemic chemotherapy directly. We describe treatment by approach rather than by drug name here; the specific regimen is discussed with your treating team and outlined on our lymphoma treatment in Hyderabad page.
Because lymphoblasts can travel to the brain and spinal cord, treatment includes CNS-directed therapy to protect the central nervous system, even when scans are clear. This is a standard, in-house part of the protocol and an important reason the modern outlook is so much better than in the past.
Radiation therapy (such as IMRT) is used selectively and is delivered directly by CION when indicated. High-intensity options such as a stem-cell transplant are reserved for selected high-risk or relapsed cases and are coordinated through accredited partner facilities rather than delivered in-house. Supportive care, nutrition and long-term survivorship follow-up are managed by our team throughout.
The outlook for children with lymphoblastic lymphoma has improved dramatically with modern leukaemia-style protocols. Published paediatric series report long-term survival broadly in the 80–90% range for localised and many advanced cases treated intensively. For context, across lymphoma types, published series report Hodgkin lymphoma survival around 80–90% and DLBCL around 60–70%; outcomes for paediatric lymphoblastic lymphoma sit at the more favourable end when treated on full protocols.
These are honest, attributed published ranges — not a CION-specific figure or a guarantee. Individual outlook varies by stage, whether the central nervous system is involved, and how the disease responds to early treatment. Your child's treating team can give a more personalised estimate. For the full picture across lymphoma types, see our lymphoma hub and, if you are comparing centres, our best lymphoma hospital in Hyderabad and best lymphoma doctors in Hyderabad pages.
Lymphoblastic lymphoma is one of several lymphomas seen in children. These sibling guides may help you compare types.
A parent-friendly starting point covering the main types of lymphoma in children and how they are diagnosed and treated.
Lymphoblastic lymphoma is a type of non-Hodgkin lymphoma — this page explains the wider NHL group in young people.
How Hodgkin lymphoma differs from the non-Hodgkin types, with its own signs, treatment and outlook.
Another fast-growing childhood non-Hodgkin lymphoma, with a distinct pattern and treatment approach.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if the T-cell or B-cell type has not yet been confirmed on immunophenotyping.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Childhood lymphoblastic lymphoma is an aggressive type of non-Hodgkin lymphoma that develops from immature lymphocytes called lymphoblasts. It is one of the more common lymphomas in children and teenagers. Most cases are of T-cell origin (child T-cell lymphoma), and these often show up as a mass in the chest behind the breastbone; a smaller share are of B-cell origin, which more often affect the skin, bone or lymph nodes. Because it grows quickly, it is treated promptly and intensively. For the wider picture, see our overview of lymphoma in children and the parent condition, lymphoblastic lymphoma.
The signs depend on where the lymphoma is. In T-cell disease, a mass in the chest can cause a persistent cough, noisy or difficult breathing, or swelling of the face and neck — these breathing symptoms can come on quickly and need urgent review. Other common signs include painless swollen lymph nodes in the neck, armpit or groin, tiredness, fever, night sweats and loss of appetite. Because these overlap with ordinary childhood illnesses, the pattern that matters is swelling or symptoms that are persistent and progressive rather than settling. Any child with fast-worsening breathing should be seen the same day. If you are worried, book a free consultation with CION.
Lymphoblastic lymphoma and acute lymphoblastic leukaemia (ALL) are closely related — they arise from the same immature lymphoblast cells and share much of their biology. The practical difference is where the disease is mainly found. When the abnormal cells form solid masses in the lymph nodes, chest or other tissues, and the bone marrow is minimally involved, it is called lymphoblastic lymphoma. When the marrow and blood are heavily involved, it is called leukaemia. By convention, more than about 25% blast cells in the bone marrow points to leukaemia. Because they overlap so much, paediatric lymphoblastic lymphoma is often treated with leukaemia-style protocols. Regimen specifics are covered on our lymphoma treatment page.
Diagnosis starts with a clinical examination and imaging — often a chest X-ray or CT to look at the mediastinal mass, and scans to map involved nodes. The diagnosis is confirmed on tissue: a biopsy of an involved node or mass, examined under the microscope and with specialised immunophenotyping to identify the lymphoblasts and whether they are T-cell or B-cell. A bone-marrow examination and a sample of the fluid around the brain and spinal cord (via lumbar puncture) check whether the marrow or central nervous system is involved, which affects the plan. CION delivers biopsy coordination, bone-marrow examination, immunophenotyping and imaging directly, following NCCN and ESMO guidance.
Because it behaves like acute lymphoblastic leukaemia, childhood lymphoblastic lymphoma is treated with intensive, prolonged combination chemotherapy given in phases over roughly two years, including treatment aimed at protecting the brain and spinal cord (CNS-directed therapy). Radiation is used selectively. CION delivers chemotherapy, CNS-directed therapy, supportive care and monitoring directly. High-intensity options such as stem-cell transplant, used only in selected relapsed or high-risk cases, are coordinated through accredited partner facilities rather than delivered in-house. We do not name specific drugs or regimens here — those details are discussed with your treating team and summarised on our lymphoma treatment in Hyderabad page.
The outlook for children with lymphoblastic lymphoma has improved greatly with modern leukaemia-style protocols. Published paediatric series report long-term survival broadly in the 80–90% range for localised and many advanced cases treated on intensive regimens, though figures vary by individual depending on stage, whether the central nervous system is involved, and how the disease responds to early treatment. These are attributed published ranges, not a CION-specific guarantee, and your child's treating team can give a more personalised estimate. For context across lymphoma types, see our lymphoma hub.
CION brings paediatric and haemato-oncology expertise together around each child, with every case reviewed by a multidisciplinary tumour board before the plan is set. Chemotherapy, CNS-directed therapy, bone-marrow examination, immunophenotyping, imaging, supportive care and long-term survivorship follow-up are delivered directly; specialist steps such as stem-cell transplant are coordinated with accredited partners. Families get a clear plan, transparent costs and a free written second opinion. This page is a bridge to our dedicated childhood lymphoma resources — to discuss your child's reports, book a free consultation or call 1800 202 8726.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.